PHARMA – March 2018

PHARMA - March 2018

Provider: OA National Provider

Contact: Optometry Australia OA Provider, [E] s.hanna@optometry.org.au, [P] 96688550

Learning Objectives

• Be more familiar with how OCT-Angiography works
• Utilise OCT-Angiography in the diagnosis of various eye diseases/conditions and use the results of OCT-Angiography to make appropriate alterations to the therapeutic medication management of patients
• Understand some of the challenges faced when prescribing topical medications for patients diagnosed with open angle glaucoma
• Understand how SLT works and the viability of SLT as a first-line treatment option in open angle glaucoma and how this might negate the need for therapeutic medication management for some patients
• Understand the mechanism whereby corticosteroid use can cause an increase in IOP and, as such, is an important risk factor in the development of open angle glaucoma
• Be more familiar with the various risk factors and epidemiology of POAG
• Understand that sleepapnoea has been linked to various ocular diseases, in particular its effect on IOP and its role in glaucoma
• Understand when monotherapy may and may not be adequate and when fixed-drop combination therapy might be a better therapeutic medication management option for certain patients
• Be more familiar with the aetiology of and management approaches to infantile nystagmus syndrome
• Understand the importance of visual field assessment and how to analyse results such that appropriate therapeutic medication management decisions can be made
• Be more familiar with the diagnosis and treatment of floaters

Max points awarded: 6.00

Session Information